We present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inhibitor.
Keywords: COVID-19; IL-6; agammaglobulinemia; convalescent plasma; inhibitor.
Copyright (c) 2020 Ivana Milosevic, Jaroslava Jovanovic, Olja Stevanovic.